-+ 0.00%
-+ 0.00%
-+ 0.00%

OMEROS' NARSOPLIMAB MEETS ITS PIVOTAL TRIAL PRIMARY ENDPOINT

Reuters·12/19/2024 14:19:40

Please log in to view news